Efficacy and safety of ustekinumab in Japanese patients with moderately to severely active Crohn's disease: a subpopulation analysis of phase 3 induction and maintenance studies-Reference-Cited by-同舟云学术

Efficacy and safety of ustekinumab in Japanese patients with moderately to severely active Crohn's disease: a subpopulation analysis of phase 3 induction and maintenance studies

Published:2017 Issue:4 Volume:15 Page:475
ISSN:1598-9100
Container-title:Intestinal Research
language:en
Short-container-title:Intest Res

Author:

Hibi Toshifumi¹,Imai Yuya²,Murata Yoko²,Matsushima Nobuko²,Zheng Richuan²,Gasink Christopher³

Affiliation:

1. Center for Advanced IBD Research and Treatment, Kitasato Institute Hospital, Kitasato University, Tokyo, Japan.

2. Janssen Pharmaceutical K.K., Tokyo, Japan.

3. Janssen Research & Development, LLC, Spring House, PA, USA.

Funder

Janssen Research and Development

Publisher

Korean Association for the Study of Intestinal Diseases

Subject

Gastroenterology

Link

https://synapse.koreamed.org/pdf/10.5217/ir.2017.15.4.475

Reference27 articles.

1. Inflammatory Bowel Disease

2. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences

3. Epidemiology and risk factors for IBD

4. Prevalence of ulcerative colitis and Crohn’s disease in Japan

5. Changing epidemiological trends of inflammatory bowel disease in Asia

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Saudi consensus guidance for the diagnosis and management of inflammatory bowel disease in children and adolescents;Saudi Journal of Gastroenterology;2024-08-30

2. A critical review of ustekinumab for the treatment of active ulcerative colitis in adults;Expert Review of Gastroenterology & Hepatology;2023-03-26

3. Real-world effectiveness and safety of ustekinumab induction therapy for Korean patients with Crohn’s disease: a KASID prospective multicenter study;Intestinal Research;2023-01-31

4. A Retrospective Cohort Study of Clinical Features and Treatment Patterns With Ustekinumab in Patients With Crohn Disease Utilizing a Health Care Database in Japan;Annals of Pharmacotherapy;2023-01-05

5. The treatment of inflammatory bowel disease with monoclonal antibodies in Asia;Biomedicine & Pharmacotherapy;2023-01